During the past decade, Center for Digestive Allergic and Immunologic Diseases conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 2 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Center for Digestive Allergic and Immunologic Diseases" #1 collaborator was "Cephalon" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Center for Digestive Allergic and Immunologic Diseases" are "Eosinophilic Esophagitis" (2 trials). Many other conditions were trialed in "Center for Digestive Allergic and Immunologic Diseases" in a lesser frequency.

Most popular intervention types in "Center for Digestive Allergic and Immunologic Diseases" are "Biological" (1 trials), "Drug" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Reslizumab" (1 trials), "Saline" (1 trials) and "reslizumab" (1 trials). Other intervention names were less common.

The vast majority of trials in "Center for Digestive Allergic and Immunologic Diseases" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Center for Digestive Allergic and Immunologic Diseases". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Center for Digestive Allergic and Immunologic Diseases, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Center for Digestive Allergic and Immunologic Diseases, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".